| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Idebenone |
| Cas number | 58186-27-9 |
| Appearance | Orange Fine Powder |
| MF | C19H30O5 |
| MW | 338.4385 |
Idebenone is a kind of new drug for treating senile dementia and improving mental symptom.Also, it is a better antioxidant in cosmetics and health care than Coenzyme Q10 and Vitamin.
Idebenone is a cure for brain function and metabolism and mental symptoms of novel anti-Alzhei mer's drug improvement. Can improve brain energy metabolism, improve brain function, and a mild antihypertensive effectClinic for cerebral infarction, cerebralhemorrhage and brain dysfunction caused by arteriosclerosis sequelae, awareness is low, patients with mood disorders, language disorders, dementia.
This product has a strong antioxidant, Idebenone is an existing product in the most effective topical antioxidant, similar species are known to breed in relatively good.
Idebenone is a synthetic variant of coenzyme Q10 (CoQ10), which initially developed for the treatment of Alzheimer's disease and other cognitive defects.Target: OthersIdebenone is a synthetic variant of coenzyme Q10 (CoQ10), which initially developed for the treatment of Alzheimer's disease and other cognitive defects. Idebenone was generally well tolerated with similar numbers of adverse events in each group. One child receiving high-dose idebenone developed neutropenia after 6 months, which resolved after discontinuation of treatment. 8OH2′dG concentrations were not increased, and did not significantly change with idebenone treatment [1]. The 2-year efficacy and safety of idebenone were studied in a prospective, randomized, double-blind multicentre study in 3 parallel groups of patients with dementia of the Alzheimer type (DAT) of mild to moderate degree. A total of 450 patients were randomized to either placebo for 12 months, followed by idebenone 90 mg tid for another 12 months (n = 153) or idebenone 90 mg tid for 24 months (n = 148) or 120 mg tid for 24 months (n = 149). idebenone showed statistically significant dose-dependent improvement in the primary efficacy variable ADAS-Total and in all the secondary efficacy variables [2].
Idebenone is a kind of new drug for treating senile dementia and improving mental symptom.Also, it is a better antioxidant in cosmetics and health care than Coenzyme Q10 and Vitamin.
Idebenone is a cure for brain function and metabolism and mental symptoms of novel anti-Alzhei mer's drug improvement. Can improve brain energy metabolism, improve brain function, and a mild antihypertensive effectClinic for cerebral infarction, cerebralhemorrhage and brain dysfunction caused by arteriosclerosis sequelae, awareness is low, patients with mood disorders, language disorders, dementia.
This product has a strong antioxidant, Idebenone is an existing product in the most effective topical antioxidant, similar species are known to breed in relatively good.
|
Item |
Specification |
Result |
Test Method |
|
|
Active Ingredeints |
||||
|
Assay(As Dried Base,%) |
98.5% to 101% |
99.68% |
HPLC |
|
|
Physical Control |
||||
|
Appearance |
orange fine Powder |
Complies |
Visual |
|
|
Color |
White to Colourless |
Complies |
Visual |
|
|
Odor &Taste |
Characteristic |
Complies |
Organoleptic |
|
|
Identification |
Positive |
Complies |
IR&1H NMR |
|
|
Loss on Drying |
≤1.0% |
0.35% |
USP |
|
|
Melting point |
97°C-98°C |
97°C-98°C |
USP |
|
|
Residue on ignition |
≤0.5% |
0.08% |
USP |
|
){kind=link}